127 related articles for article (PubMed ID: 16782180)
1. Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
Olsen CK; Kreilgaard M; Didriksen M
Pharmacol Biochem Behav; 2006 Jun; 84(2):259-65. PubMed ID: 16782180
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
Jardemark K; Marcus MM; Malmerfelt A; Shahid M; Svensson TH
Psychopharmacology (Berl); 2012 May; 221(1):115-31. PubMed ID: 22068461
[TBL] [Abstract][Full Text] [Related]
3. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
Ashby DM; Lapish CC; Phillips AG
Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
[TBL] [Abstract][Full Text] [Related]
4. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Olsen CK; Brennum LT; Kreilgaard M
Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
Marcus MM; Wiker C; Frånberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
[TBL] [Abstract][Full Text] [Related]
6. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
7. Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats.
Titulaer J; Radhe O; Mazrina J; Ström A; Svensson TH; Konradsson-Geuken Å
Eur Neuropsychopharmacol; 2022 Jul; 60():48-54. PubMed ID: 35635996
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
Morimoto T; Hashimoto K; Yasumatsu H; Tanaka H; Fujimura M; Kuriyama M; Kimura K; Takehara S; Yamagami K
Neuropsychopharmacology; 2002 Apr; 26(4):456-67. PubMed ID: 11927170
[TBL] [Abstract][Full Text] [Related]
10. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
11. Effects of typical and atypical antipsychotics on human glycine transporters.
Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
13. Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.
Ahnaou A; Huysmans H; Van de Casteele T; Drinkenburg WHIM
Transl Psychiatry; 2017 Dec; 7(12):1285. PubMed ID: 29249806
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
15. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
16. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Wadenberg ML; Wiker C; Svensson TH
Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
[TBL] [Abstract][Full Text] [Related]
17. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.
Tarazi FI; Moran-Gates T; Gardner MP; Graulich A; Lamy C; Liégeois JF
J Mol Neurosci; 2007; 32(3):192-8. PubMed ID: 17873364
[TBL] [Abstract][Full Text] [Related]
19. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Arvanov VL; Wang RY
Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
[TBL] [Abstract][Full Text] [Related]
20. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
Feng M; Sparkman NL; Sui N; Li M
J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]